You are here

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Lexington, Kentucky, 40536-0098 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Tumors, Neoplasms
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Documented diagnosis of malignant solid tumor with measurable disease

- Life expectancy of at least 12 weeks

- ECOG (The Eastern Cooperative Oncology Group scale) performance status of 0, 1, or 2

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Recent major surgery, radiation therapy or anti-cancer treatment

- History of any other prior malignancy within the last 5 years

NCT00195325
Pfizer
Terminated
Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
NCT00063427
All Genders
Liver Neoplasms, Unresectable Hepatocellular Carcinoma
NCT00247676
All Genders
18+
Years
Multiple Sites
Colorectal Neoplasms, Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Pancreatic Neoplasms
NCT00034827
All Genders
18+
Years
Multiple Sites
Advanced Solid Tumors
NCT01999972
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now